RECRUIT Site List.

Blood and Marrow Transplant Clinical Trials Network (BMT CTN)

City of Hope National Medical Center, Duarte, CA Duke University, Durham, NC Emory University, Atlanta, GA Johns Hopkins University, Baltimore, MD Memorial Sloan Kettering Cancer Center, New York, NY Moffitt Cancer Center, Tampa, FL Northside Hospital, Atlanta, GA Oregon Health Sciences University, Portland, OR University of Florida, Gainesville, FL University of Kansas Medical Center, Westwood, KS University of Pennsylvania, Philadelphia, PA University of Texas MD Anderson Cancer Center, Houston, TX Washington University School of Medicine in St. Louis, St. Louis, MO

Catheter Ablation versus Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial (CABANA)

Augusta University, previously Georgia Regents University, Augusta, GA Cooper University Hospital, Camden, NJ Duke University Medical Center, Durham, NC Fort Worth Heart PA/Baylor All Saints Medical Center, Fort Worth, TX Georgia Arrhythmia Consultants, Macon, GA Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ Scott and White Memorial Hospital, Temple, TX Swedish Medical Center- Providence Campus, Seattle, WA The University of California at San Francisco Medical Center, San Francisco, CA University of North Carolina at Chapel Hill, Chapel Hill, NC

Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES)

Columbia University Medical Center, New York, NY Dwight D. Eisenhower Army Medical Center, Augusta, GA Gibbs Cancer Center, Spartanburg Regional Healthcare System, Spartenburg, SC Greenville Health System, Greenville, SC Lewis Cancer & Research Pavilion at St. Joseph’s/Candler Health System, Inc, Savannah, GA Loyola University Medical Center, Maywood, IL Nevada Cancer Research Foundation, Las Vegas, NV Sinai Hospital of Baltimore, Baltimore, MD University of California Irvine, Orange, CA University of Hawaii, Honolulu, HI/ and The Queen’s Medical Center, Honolulu, HI*

Preventing Adenomas of the Colon with Eflornithine and Sulindac (PACES) Continued

University of Mississippi Medical Center, Jackson, MS University of Texas Health Science Center at San Antonio, San Antonio, TX Weiss Hospital, Chicago, IL/ and West Suburban Hospital, Berwyn, IL*

Efficacy of Isradipine in Early Parkinson Disease (STEADY-PD III)

Atlantic Health System, Summit, NJ Banner Sun Health Research Institute, Sun City, AZ John Hopkins, Baltimore, MD North Shore LIJ Health System/Feinstein Institute, Manhasset NY Northwestern University Feinberg School of Medicine, Chicago, IL Rush University, Chicago, IL The Parkinson’s & Movement Disorder Institute, Fountain Valley, CA University of California San Diego, La Jolla, CA University of Alabama at Birmingham, Birmingham, AL University of California Irvine, Irvine, CA University of Maryland, Baltimore, MD University of Nevada Las Vegas School of Medicine, Las Vegas, NV University of Pennsylvania, Philadelphia, PA University of Texas Health Science Center-Medical School, Houston, Texas

^*At kickoff meeting, after randomization we discovered these two set of sites had two geographically separated facilities so they were split into two sub-sites. The sub-sites each submitted a screening log and recruitment activities check list but were treated as one site during the analysis.